Waldencast plc (WALD)
NASDAQ: WALD · Real-Time Price · USD
1.570
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST - Market closed

Company Description

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand.

The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products.

In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products.

It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers.

The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Waldencast plc
Waldencast logo
Country United Kingdom
Founded 1988
IPO Date Mar 16, 2021
Industry Shell Companies
Sector Financials
Employees 335
CEO Michel Brousset

Contact Details

Address:
81 Fulham Road, Suite 560
London, SW3 6RD
United Kingdom
Phone 44 20 3196 0264
Website waldencast.com

Stock Details

Ticker Symbol WALD
Exchange NASDAQ
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $10.00
CIK Code 0001840199
CUSIP Number G9503X103
ISIN Number JE00BPG99318
SIC Code 2844

Key Executives

Name Position
Michel Brousset Founder, Chief Executive Officer and Director
Hind Sebti Co-Founder, Chief Growth Officer and Director
Manuel Manfredi Chief Financial Officer
Elisabeth Milan General Counsel

Latest SEC Filings

Date Type Title
Jan 15, 2026 6-K Report of foreign issuer
Dec 19, 2025 6-K Report of foreign issuer
Dec 18, 2025 EFFECT Notice of Effectiveness
Dec 18, 2025 424B3 Prospectus
Dec 4, 2025 F-3 Filing
Nov 24, 2025 6-K Report of foreign issuer
Nov 24, 2025 6-K Report of foreign issuer
Nov 14, 2025 6-K Report of foreign issuer
Sep 10, 2025 6-K Report of foreign issuer
Sep 4, 2025 SCHEDULE 13G Filing